Scholars Central

Conference abstract

Fast dissolving drug delivery systems

Authors: Gulay Yelken Demırel

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Fast-dissolving formulations represent excellent opportunities for life cycle management to the pharmaceutical companies. Fast dissolving technologies have many advantages like ease of swallowing, administration without water, quick onset of action for improving both patient convenience and compliance as benefits for patient; extended life cycle, product differentiation, patent protection as benefits for pharmaceutical companies. But there are some challenges for formulation development studies like taste-masking, disintegration time, moisture sensitivity, friability, packaging and intellectual property issues especially for the generic companies. The technologies are under patent protection like Zydis?, Flashtab?, OraSolv? and DuraSolv?, WOWTAB?. One of major issues is taste-masking problem, may be overcome with using cyclodextrins, polymer coating, flavoring&sweetening agent, microencapsulation techniques. There are some modified excipients for providing both taste-masking and productability properities in the formulation like Ludiflash? and Pharmaburst?. From the analytical development point of view there are a number of different methods from conventional dosage forms which are determined in the Pharmacopoeias. And for comparison and assessment of taste masking, electronic tongue may be a good opportunity which was developed by Alpha M.O.S. In the sense of generic companies, developing a fast dissolving tablet version of an existing immediate-release product means that the two formulations must be bioequivalent and this can be challenging for invivo studies especially if the method of taste masking retards the dissolution rate of the active ingredient after disintegration. What about the future of fast dissolving technologies? Orally disintegrating extended Release (ODT-ER) dosage forms are providing all of the benefits of these two drug delivery technologies in a single pharmaceutical product. And oral rapid films also may be a good alternative especially for the OTC market.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutica Analytica Acta.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Gulay Yelken Demırel”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels